Cargando…

Performance analysis of novel toxin-antidote CRISPR gene drive systems

BACKGROUND: CRISPR gene drive systems allow the rapid spread of a genetic construct throughout a population. Such systems promise novel strategies for the management of vector-borne diseases and invasive species by suppressing a target population or modifying it with a desired trait. However, curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Champer, Jackson, Kim, Isabel K., Champer, Samuel E., Clark, Andrew G., Messer, Philipp W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068947/
https://www.ncbi.nlm.nih.gov/pubmed/32164660
http://dx.doi.org/10.1186/s12915-020-0761-2
_version_ 1783505678079361024
author Champer, Jackson
Kim, Isabel K.
Champer, Samuel E.
Clark, Andrew G.
Messer, Philipp W.
author_facet Champer, Jackson
Kim, Isabel K.
Champer, Samuel E.
Clark, Andrew G.
Messer, Philipp W.
author_sort Champer, Jackson
collection PubMed
description BACKGROUND: CRISPR gene drive systems allow the rapid spread of a genetic construct throughout a population. Such systems promise novel strategies for the management of vector-borne diseases and invasive species by suppressing a target population or modifying it with a desired trait. However, current homing-type drives have two potential shortcomings. First, they can be thwarted by the rapid evolution of resistance. Second, they lack any mechanism for confinement to a specific target population. In this study, we conduct a comprehensive performance assessment of several new types of CRISPR-based gene drive systems employing toxin-antidote (TA) principles, which should be less prone to resistance and allow for the confinement of drives to a target population due to invasion frequency thresholds. RESULTS: The underlying principle of the proposed CRISPR toxin-antidote gene drives is to disrupt an essential target gene while also providing rescue by a recoded version of the target as part of the drive allele. Thus, drive alleles tend to remain viable, while wild-type targets are disrupted and often rendered nonviable, thereby increasing the relative frequency of the drive allele. Using individual-based simulations, we show that Toxin-Antidote Recessive Embryo (TARE) drives targeting an haplosufficient but essential gene (lethal when both copies are disrupted) can enable the design of robust, regionally confined population modification strategies with high flexibility in choosing promoters and targets. Toxin-Antidote Dominant Embryo (TADE) drives require a haplolethal target gene and a germline-restricted promoter, but they could permit faster regional population modification and even regionally confined population suppression. Toxin-Antidote Dominant Sperm (TADS) drives can be used for population modification or suppression. These drives are expected to spread rapidly and could employ a variety of promoters, but unlike TARE and TADE, they would not be regionally confined and also require highly specific target genes. CONCLUSIONS: Overall, our results suggest that CRISPR-based TA gene drives provide promising candidates for flexible ecological engineering strategies in a variety of organisms.
format Online
Article
Text
id pubmed-7068947
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70689472020-03-18 Performance analysis of novel toxin-antidote CRISPR gene drive systems Champer, Jackson Kim, Isabel K. Champer, Samuel E. Clark, Andrew G. Messer, Philipp W. BMC Biol Research Article BACKGROUND: CRISPR gene drive systems allow the rapid spread of a genetic construct throughout a population. Such systems promise novel strategies for the management of vector-borne diseases and invasive species by suppressing a target population or modifying it with a desired trait. However, current homing-type drives have two potential shortcomings. First, they can be thwarted by the rapid evolution of resistance. Second, they lack any mechanism for confinement to a specific target population. In this study, we conduct a comprehensive performance assessment of several new types of CRISPR-based gene drive systems employing toxin-antidote (TA) principles, which should be less prone to resistance and allow for the confinement of drives to a target population due to invasion frequency thresholds. RESULTS: The underlying principle of the proposed CRISPR toxin-antidote gene drives is to disrupt an essential target gene while also providing rescue by a recoded version of the target as part of the drive allele. Thus, drive alleles tend to remain viable, while wild-type targets are disrupted and often rendered nonviable, thereby increasing the relative frequency of the drive allele. Using individual-based simulations, we show that Toxin-Antidote Recessive Embryo (TARE) drives targeting an haplosufficient but essential gene (lethal when both copies are disrupted) can enable the design of robust, regionally confined population modification strategies with high flexibility in choosing promoters and targets. Toxin-Antidote Dominant Embryo (TADE) drives require a haplolethal target gene and a germline-restricted promoter, but they could permit faster regional population modification and even regionally confined population suppression. Toxin-Antidote Dominant Sperm (TADS) drives can be used for population modification or suppression. These drives are expected to spread rapidly and could employ a variety of promoters, but unlike TARE and TADE, they would not be regionally confined and also require highly specific target genes. CONCLUSIONS: Overall, our results suggest that CRISPR-based TA gene drives provide promising candidates for flexible ecological engineering strategies in a variety of organisms. BioMed Central 2020-03-12 /pmc/articles/PMC7068947/ /pubmed/32164660 http://dx.doi.org/10.1186/s12915-020-0761-2 Text en © The Author(s). 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Champer, Jackson
Kim, Isabel K.
Champer, Samuel E.
Clark, Andrew G.
Messer, Philipp W.
Performance analysis of novel toxin-antidote CRISPR gene drive systems
title Performance analysis of novel toxin-antidote CRISPR gene drive systems
title_full Performance analysis of novel toxin-antidote CRISPR gene drive systems
title_fullStr Performance analysis of novel toxin-antidote CRISPR gene drive systems
title_full_unstemmed Performance analysis of novel toxin-antidote CRISPR gene drive systems
title_short Performance analysis of novel toxin-antidote CRISPR gene drive systems
title_sort performance analysis of novel toxin-antidote crispr gene drive systems
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068947/
https://www.ncbi.nlm.nih.gov/pubmed/32164660
http://dx.doi.org/10.1186/s12915-020-0761-2
work_keys_str_mv AT champerjackson performanceanalysisofnoveltoxinantidotecrisprgenedrivesystems
AT kimisabelk performanceanalysisofnoveltoxinantidotecrisprgenedrivesystems
AT champersamuele performanceanalysisofnoveltoxinantidotecrisprgenedrivesystems
AT clarkandrewg performanceanalysisofnoveltoxinantidotecrisprgenedrivesystems
AT messerphilippw performanceanalysisofnoveltoxinantidotecrisprgenedrivesystems